Commentary|Articles|November 20, 2026

AJMC® in the Press, November 20, 2026

Author(s)Habiba Atta
Fact checked by: Maggie L. Shaw
Listen
0:00 / 0:00

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The study, “Low Colorectal Cancer Screening Among Adults Aged 45-49 Years in the US, 2023,” was published in The American Journal of Managed Care® (AJMC®) in March 2026 by Yize Richard Wang, MD, PhD, of Cooper Medical School of Rowan University and Cooper Digestive Health Institute. This analysis, which used 2023 National Health Interview Survey data, found that 36.1% of adults aged 45 to 49 years were up to date on colorectal cancer screening vs 55.6% of those aged 50 to 54 years. Wang concluded that interventions aimed at specific age groups may help raise screening rates.

In a November 2026 article about CMS’ final 2027 outpatient and ambulatory surgical center (ASC) payment rule, Becker’s ASC Review noted that CMS projects a 1% drop in 2027 Medicare ASC payments for GI procedures. It cited the AJMC analysis’ 36.1% and 55.6% screening rates to support the argument that rising demand may soften the Medicare cut.

The article, “Lung Transplant Trends Shift to Older Adults, Sicker Pediatric Cases,” published on AJMC.com in September 2026, reported findings presented at the European Respiratory Society Congress 2026. It showed that patients aged 70 and older now make up 13% of lung transplant recipients worldwide, up from 1% two decades ago. It also noted that International Society for Heart and Lung Transplantation guidance treats age as a risk factor from 65 to 70 years and a high-risk factor beyond age 70 years, not as a cutoff.

Nacionale cited the AJMC article to explain whether there is an age limit for lung transplants, after the golfer Rory McIlroy’s 67-year-old father had a double lung transplant. It said that at 67 years, age counts against a patient but doesn’t rule them out, and it used AJMC’s registry figures to show that older adults are the fastest-growing group of recipients, but that 5-year survival is about 16% lower for recipients 65 and older.

The article, “US Measles Outbreaks Cost Nearly $83 Million in 2026,” published on AJMC.com in November 2026, reported estimates from a Johns Hopkins University measles tracker. Outbreaks in 2026 cost nearly $83 million, including about $56 million for public health response and almost $25 million in lost productivity. This is more than double the estimated $37 million in 2025.

news.com.au reported in November 2026 that the US had lost its measles elimination status, linking the loss to falling vaccination rates and citing AJMC’s $83 million estimate of this year’s outbreak costs. Total medical costs since the outbreak began are estimated at about $125 million and rising.

The article, “Clinicians Cite Progress Tracking as Top Barrier in Value-Based Care,” published on AJMC.com in December 2025, covered a survey released by Twofold Health in October 2025. Of 446 clinicians, 36% named progress tracking as their biggest challenge, more than double the 15.5% who cited insurance issues. Healthcare IT Today also drew on “Physicians in ACOs Report Greater Documentation Burden,” a study published in AJMC in May 2024, which found that taking part in any value-based payment program was associated with a 10.5% greater probability of reporting more than 1 hour per day of after-hours documentation time. Most of that effect came from accountable care organizations.

Healthcare IT Today argued that CMS’ ACCESS model puts pressure on technology because it rewards measurable, patient-level outcomes for chronic conditions. It cited the survey highlighted by AJMC, which found that tracking patient progress was the top barrier to value-based care. The article used that finding to show how hard it will be to measure individual outcomes at the scale ACCESS requires.


Related to this article